Zhejiang University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

216

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

35 drugs in development

Phase 31

Phase 27

Phase 125

Preclinical4

By Therapeutic Area

top 3

Oncology

2872%

Cardiovascular

13%

Immunology

13%

R&D Momentum

81/100

Pipeline Velocity

51/100

Trial Completion Rate

74/100

Pipeline Concentration

57/100

Pipeline Freshness

59/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 16, 2026

Active, not recruiting

Clinical Research on the Use of Non-contrast CT Combined With AI for Early Screening for Liver Malignancy

Sep 11, 2026

Recruiting

Physician and Patient Preferences for Cell Therapies in Advanced Solid Tumors: A Discrete Choice Experiment

Sep 9, 2026

Completed

Efficacy and Safety of Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica (ITTG PMR): An Open-label 52-week Randomized Controlled Trial

Earlier

Sep 1, 2026TrialA Phase Ib/II Study of the Safety, Tolerability, and Efficacy of a Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer

Aug 29, 2026TrialHigh-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease: A Single-Arm Simon Two-Stage Study

Aug 28, 2026TrialNeoadjuvant Encorafenib, Cetuximab N01 and mFolfox6 for BRAF V600E Mutated/ pMMR Localized Colorectal Cancer With or Without Resectable Metastases: a Single Arm, Multi-center, Phase 2 Clinical Trial

Aug 25, 2026TrialSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research

Aug 21, 2026TrialThe Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery：Two-Stage Designs for Phase II Clinical Trials

1 more events

Aug 18, 2026TrialEffects of Sensor- and Generative AI-Supported Personalized Feedback on the Acquisition of Standardized Tuina Skills Among Rehabilitation Trainees: A Randomized Controlled Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Immunology(1 drug)

—

Immunology(1 drug)

Oncology(28 drugs)

—

Oncology(28 drugs)

Unknown / Other(9 drugs)

—

Unknown / Other(9 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)